{'fraction_non_alphanumeric': 0.02028397565922921, 'fraction_numerical': 0.012170385395537525, 'mean_word_length': 5.175, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Cancer Research: The lessons to learn from COVID-19.

The COVID-19 pandemic has caused widespread disruption of cancer clinical trials due to the restrictions on non-essential services and the re-allocation of resources, and at the same time the urgent global effort towards discovering therapies that treat or prevent COVID-19 infection has led to shortening of traditional regulatory timelines. This experience should stimulate similar urgency in the way future cancer research is conducted.